FDA Roundup: March 22, 2024
This post was originally published on this siteSILVER SPRING, Md., March 22, 2024 /PRNewswire/ — Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA issued an emergency use authorization for Pemgarda (pemivibart) for the pre-exposure prophylaxis (prevention)…
Continue Reading